ALS 'Compassionate Use' Again Hits National Media

(MedPage Today) -- When Neil Shneider, MD, PhD, got results back that Lisa Stockman Mauriello's amyotrophic lateral sclerosis (ALS) was driven by a SOD1 mutation, enrollment in the VALOR study had just closed.
The phase III trial is testing Biogen...